• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野生型 Jak2 等位基因缺失增强 Jak2V617F 敲入小鼠中髓系细胞的扩增并加速骨髓纤维化。

Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice.

机构信息

Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, USA.

Department of Pathology, SUNY Upstate Medical University, Syracuse, NY, USA.

出版信息

Leukemia. 2014 Aug;28(8):1627-35. doi: 10.1038/leu.2014.52. Epub 2014 Jan 31.

DOI:10.1038/leu.2014.52
PMID:24480985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4117831/
Abstract

JAK2V617F is the most common mutation found in Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs). Although a majority of MPN patients carry heterozygous JAK2V617F mutation, loss of heterozygosity (LOH) on chromosome 9p (9pLOH) involving the JAK2 locus has been observed in ∼30% of MPN patients. JAK2V617F homozygosity via 9pLOH has been associated with more severe MPN phenotype. However, the contribution of 9pLOH in the pathogenesis of MPNs remains unclear. To investigate the roles of wild-type JAK2 (JAK2 WT) and JAK2V617F alleles in the development of MPNs, we have used conditional Jak2 knock-out and Jak2V617F knock-in mice and generated heterozygous, hemizygous and homozygous Jak2V617F mice. Whereas heterozygous Jak2V617F expression results in a polycythemia vera-like MPN in mice, loss of Jak2 WT allele in hemizygous or homozygous Jak2V617F mice results in markedly increased white blood cells, neutrophils, reticulocytes and platelets in the peripheral blood, and significantly larger spleen size compared with heterozygous Jak2V617F mice. Hemizygous or homozygous Jak2V617F mice also exhibit accelerated myelofibrosis compared with mice expressing heterozygous Jak2V617F. Together, these results suggest that loss of Jak2 WT allele increases the severity of the MPN. Thus, the Jak2 WT allele functions as a negative regulator of MPN induced by Jak2V617F.

摘要

JAK2V617F 是费城染色体阴性骨髓增殖性肿瘤(MPN)中最常见的突变。虽然大多数 MPN 患者携带杂合 JAK2V617F 突变,但在约 30%的 MPN 患者中观察到涉及 JAK2 基因座的 9 号染色体短臂缺失(9pLOH)。JAK2V617F 纯合子通过 9pLOH 与更严重的 MPN 表型相关。然而,9pLOH 在 MPN 发病机制中的作用仍不清楚。为了研究野生型 JAK2(JAK2 WT)和 JAK2V617F 等位基因在 MPN 发病机制中的作用,我们使用了条件性 Jak2 敲除和 Jak2V617F 敲入小鼠,并生成了杂合子、半合子和纯合子 Jak2V617F 小鼠。虽然杂合子 Jak2V617F 表达导致小鼠出现类似真性红细胞增多症的 MPN,但在半合子或纯合子 Jak2V617F 小鼠中丢失 Jak2 WT 等位基因会导致外周血白细胞、中性粒细胞、网织红细胞和血小板显著增加,与杂合子 Jak2V617F 小鼠相比,脾脏明显增大。半合子或纯合子 Jak2V617F 小鼠还表现出比表达杂合子 Jak2V617F 的小鼠更快的骨髓纤维化。这些结果表明,Jak2 WT 等位基因的缺失增加了 MPN 的严重程度。因此,Jak2 WT 等位基因作为 Jak2V617F 诱导的 MPN 的负调节剂发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/b7e77ee4d961/nihms560853f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/a7a7686a75bc/nihms560853f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/912d79e9f01d/nihms560853f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/e70266f86f81/nihms560853f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/b9209fa06a8f/nihms560853f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/a805bf2d08e6/nihms560853f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/b7e77ee4d961/nihms560853f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/a7a7686a75bc/nihms560853f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/912d79e9f01d/nihms560853f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/e70266f86f81/nihms560853f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/b9209fa06a8f/nihms560853f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/a805bf2d08e6/nihms560853f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25b/4117831/b7e77ee4d961/nihms560853f6.jpg

相似文献

1
Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice.野生型 Jak2 等位基因缺失增强 Jak2V617F 敲入小鼠中髓系细胞的扩增并加速骨髓纤维化。
Leukemia. 2014 Aug;28(8):1627-35. doi: 10.1038/leu.2014.52. Epub 2014 Jan 31.
2
A gain-of-function mutation of JAK2 in myeloproliferative disorders.骨髓增殖性疾病中JAK2的功能获得性突变。
N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113.
3
Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice.由 JAK2V617F 组成性表达在敲入小鼠中诱导的骨髓增殖性肿瘤。
Blood. 2010 Aug 5;116(5):783-7. doi: 10.1182/blood-2009-12-257063. Epub 2010 May 14.
4
Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms.克隆分析确定了Ph阴性骨髓增殖性肿瘤患者染色体异常与JAK2V617F之间的关系。
Exp Hematol. 2009 Oct;37(10):1194-200. doi: 10.1016/j.exphem.2009.07.003. Epub 2009 Jul 15.
5
Deletion of Stat3 enhances myeloid cell expansion and increases the severity of myeloproliferative neoplasms in Jak2V617F knock-in mice.在Jak2V617F基因敲入小鼠中,Stat3基因的缺失增强了髓系细胞的扩增,并增加了骨髓增殖性肿瘤的严重程度。
Leukemia. 2015 Oct;29(10):2050-61. doi: 10.1038/leu.2015.116. Epub 2015 May 18.
6
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.条件性表达杂合或纯合 Jak2V617F 从其内源启动子诱导类似于真性红细胞增多症的疾病。
Blood. 2010 Apr 29;115(17):3589-97. doi: 10.1182/blood-2009-04-215848. Epub 2010 Mar 2.
7
Clinical Impact of Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms.费城阴性骨髓增殖性肿瘤等位基因负担的临床影响。
Turk J Haematol. 2023 Aug 31;40(3):174-182. doi: 10.4274/tjh.galenos.2023.2023.0169. Epub 2023 Aug 16.
8
Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates.9p24 染色体异常:发生率、新型 JAK2 易位描述、JAK2V617F 突变分析及临床病理相关性。
Eur J Haematol. 2010 Jun;84(6):518-24. doi: 10.1111/j.1600-0609.2010.01428.x. Epub 2010 Mar 11.
9
Relationship between the 46/1 haplotype of the JAK2 gene and the JAK2 mutational status and allele burden, the initial findings, and the survival of patients with myelofibrosis.原发性骨髓纤维化患者 JAK2 基因 46/1 单体型与 JAK2 突变状态及等位基因负担的关系:初步研究结果与患者生存情况。
Ann Hematol. 2014 May;93(5):797-802. doi: 10.1007/s00277-013-1989-5. Epub 2013 Dec 15.
10
Study on the Clinical Significance of JAK2V617F Allele Burden in Philadelphia Chromosome-Negative Myeloproliferative Neoplasm.JAK2V617F等位基因负荷在费城染色体阴性骨髓增殖性肿瘤中的临床意义研究
Clin Lab. 2016 Aug 1;62(8):1477-1481. doi: 10.7754/Clin.Lab.2016.151208.

引用本文的文献

1
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.通过常规配对的肿瘤和正常测序增强血液系统恶性肿瘤的临床评估。
Nat Commun. 2023 Oct 28;14(1):6895. doi: 10.1038/s41467-023-42585-9.
2
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice.Jak2 和 Ikk2 在小鼠造血中的补充和拮抗作用。
Exp Hematol. 2023 Dec;128:48-66. doi: 10.1016/j.exphem.2023.08.005. Epub 2023 Aug 21.
3
Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm.

本文引用的文献

1
Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans.条件性敲除 Jak2 揭示了其在整个小鼠胚胎发生过程中对造血的重要作用:对人类 Jak2 抑制的影响。
PLoS One. 2013;8(3):e59675. doi: 10.1371/journal.pone.0059675. Epub 2013 Mar 27.
2
Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model.羟基脲和 INC424 对 JAK2-V617F 真性红细胞增多症小鼠模型中突变等位基因负担和骨髓增殖表型的差异影响。
Blood. 2013 Feb 14;121(7):1188-99. doi: 10.1182/blood-2012-03-415646. Epub 2012 Dec 20.
3
白细胞介素-1 有助于 JAK2V617F 诱导的骨髓增殖性肿瘤中骨髓纤维化的克隆扩张和进展。
Nat Commun. 2022 Sep 13;13(1):5347. doi: 10.1038/s41467-022-32928-3.
4
Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models.基因敲除 Pim1 或用 TP-3654 进行药理抑制可改善小鼠模型中的骨髓纤维化。
Leukemia. 2022 Mar;36(3):746-759. doi: 10.1038/s41375-021-01464-2. Epub 2021 Nov 5.
5
CDK6 Is a Therapeutic Target in Myelofibrosis.CDK6 是骨髓纤维化的治疗靶点。
Cancer Res. 2021 Aug 15;81(16):4332-4345. doi: 10.1158/0008-5472.CAN-21-0590. Epub 2021 Jun 18.
6
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis.染色体改变和基因突变之间的相互作用塑造了克隆性造血的进化轨迹。
Nat Commun. 2021 Jan 12;12(1):338. doi: 10.1038/s41467-020-20565-7.
7
Myeloproliferative neoplasms: from origins to outcomes.骨髓增殖性肿瘤:从起源到结局。
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):470-479. doi: 10.1182/asheducation-2017.1.470.
8
Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm.在骨髓增殖性肿瘤小鼠模型中,Ezh2缺失与Jak2V617F共同作用促进骨髓纤维化的发展。
Blood. 2016 Jun 30;127(26):3410-23. doi: 10.1182/blood-2015-11-679431. Epub 2016 Apr 14.
9
Molecular classification of myeloproliferative neoplasms-pros and cons.骨髓增殖性肿瘤的分子分类:利弊。
Curr Hematol Malig Rep. 2013 Dec;8(4):342-50. doi: 10.1007/s11899-013-0179-9.
Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.
骨髓纤维化患者的脾脏中含有恶性造血干细胞。
J Clin Invest. 2012 Nov;122(11):3888-99. doi: 10.1172/JCI64397.
4
Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice.野生型等位基因的缺失导致 FLT3/ITD 敲入小鼠髓系细胞扩增和疾病侵袭性增强。
Blood. 2011 Nov 3;118(18):4935-45. doi: 10.1182/blood-2011-01-328096. Epub 2011 Sep 8.
5
JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy.原发性骨髓纤维化中 JAK2(V617F)等位基因负担与纤维化程度相关,但治疗对其影响不大。
Leuk Res. 2011 Feb;35(2):177-82. doi: 10.1016/j.leukres.2010.06.017. Epub 2010 Jul 22.
6
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.一项对 338 例真性红细胞增多症患者的前瞻性研究:JAK2(V617F)等位基因负担和白细胞增多对纤维化或白血病转化及血管并发症的影响。
Leukemia. 2010 Sep;24(9):1574-9. doi: 10.1038/leu.2010.148. Epub 2010 Jul 15.
7
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells.生理 Jak2V617F 表达导致致命的骨髓增殖性肿瘤,并对造血干/祖细胞产生不同的影响。
Cancer Cell. 2010 Jun 15;17(6):584-96. doi: 10.1016/j.ccr.2010.05.015.
8
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.JAK2 V617F 损害条件性敲入 JAK2 V617F 阳性原发性血小板增多症小鼠模型中造血干细胞的功能。
Blood. 2010 Sep 2;116(9):1528-38. doi: 10.1182/blood-2009-12-259747. Epub 2010 May 20.
9
Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice.由 JAK2V617F 组成性表达在敲入小鼠中诱导的骨髓增殖性肿瘤。
Blood. 2010 Aug 5;116(5):783-7. doi: 10.1182/blood-2009-12-257063. Epub 2010 May 14.
10
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.条件性表达杂合或纯合 Jak2V617F 从其内源启动子诱导类似于真性红细胞增多症的疾病。
Blood. 2010 Apr 29;115(17):3589-97. doi: 10.1182/blood-2009-04-215848. Epub 2010 Mar 2.